AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,834,000 | -34.4% | 210,920 | +1.1% | 0.02% | -51.4% |
| Q2 2019 | $10,410,000 | -27.0% | 208,700 | -1.3% | 0.04% | -32.7% |
| Q1 2019 | $14,261,000 | +44.2% | 211,460 | -1.4% | 0.05% | +26.8% |
| Q4 2018 | $9,890,000 | -46.1% | 214,480 | -9.9% | 0.04% | -36.9% |
| Q3 2018 | $18,358,000 | -10.1% | 238,050 | -1.8% | 0.06% | +85.7% |
| Q2 2018 | $20,418,000 | -0.7% | 242,410 | -3.6% | 0.04% | -2.8% |
| Q1 2018 | $20,560,000 | – | 251,410 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |